Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Completed1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

completed133%
terminated133%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.

NCT02633124
withdrawnnot_applicable

Evaluation of Extended Wear Infusion Set With 670G Hybrid Closed-Loop Therapy

NCT04284033
completedphase_1

Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set

NCT02687256

Clinical Trials (3)

Showing 3 of 3 trials
NCT02633124Not Applicable

Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.

Terminated
NCT04284033Not Applicable

Evaluation of Extended Wear Infusion Set With 670G Hybrid Closed-Loop Therapy

Withdrawn
NCT02687256Phase 1

Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3